299 related articles for article (PubMed ID: 34111307)
1. Overdoses due to fentanyl and its analogues (F/FAs) push naloxone to the limit.
Pergolizzi JV; Dahan A; Ann LeQuang J; Raffa RB
J Clin Pharm Ther; 2021 Dec; 46(6):1501-1504. PubMed ID: 34111307
[TBL] [Abstract][Full Text] [Related]
2. Wooden Chest syndrome: The atypical pharmacology of fentanyl overdose.
Pergolizzi JV; Webster LR; Vortsman E; Ann LeQuang J; Raffa RB
J Clin Pharm Ther; 2021 Dec; 46(6):1505-1508. PubMed ID: 34240442
[TBL] [Abstract][Full Text] [Related]
3. Fentanyl causes naloxone-resistant vocal cord closure: A platform for testing opioid overdose treatments.
Miner NB; Schutzer WE; Zarnegarnia Y; Janowsky A; Torralva R
Drug Alcohol Depend; 2021 Oct; 227():108974. PubMed ID: 34492557
[TBL] [Abstract][Full Text] [Related]
4. Examination of naloxone dosing patterns for opioid overdose by emergency medical services in Kentucky during increased fentanyl use from 2018 to 2021.
Rock P; Slavova S; Westgate PM; Nakamura A; Walsh SL
Drug Alcohol Depend; 2024 Feb; 255():111062. PubMed ID: 38157702
[TBL] [Abstract][Full Text] [Related]
5. Naloxone dosing in the era of ultra-potent opioid overdoses: a systematic review.
Moe J; Godwin J; Purssell R; O'Sullivan F; Hau JP; Purssell E; Curran J; Doyle-Waters MM; Brasher PMA; Buxton JA; Hohl CM
CJEM; 2020 Mar; 22(2):178-186. PubMed ID: 31955714
[TBL] [Abstract][Full Text] [Related]
6. Amount of naloxone used to reverse opioid overdoses outside of medical practice in a city with increasing illicitly manufactured fentanyl in illicit drug supply.
Bell A; Bennett AS; Jones TS; Doe-Simkins M; Williams LD
Subst Abus; 2019; 40(1):52-55. PubMed ID: 29558283
[No Abstract] [Full Text] [Related]
7. Stronger, longer, better opioid antagonists? Nalmefene is NOT a naloxone replacement.
Infante AF; Elmes AT; Gimbar RP; Messmer SE; Neeb C; Jarrett JB
Int J Drug Policy; 2024 Feb; 124():104323. PubMed ID: 38232438
[TBL] [Abstract][Full Text] [Related]
8. Fentanyl depression of respiration: Comparison with heroin and morphine.
Hill R; Santhakumar R; Dewey W; Kelly E; Henderson G
Br J Pharmacol; 2020 Jan; 177(2):254-266. PubMed ID: 31499594
[TBL] [Abstract][Full Text] [Related]
9. Estimating naloxone need in the USA across fentanyl, heroin, and prescription opioid epidemics: a modelling study.
Irvine MA; Oller D; Boggis J; Bishop B; Coombs D; Wheeler E; Doe-Simkins M; Walley AY; Marshall BDL; Bratberg J; Green TC
Lancet Public Health; 2022 Mar; 7(3):e210-e218. PubMed ID: 35151372
[TBL] [Abstract][Full Text] [Related]
10. Opioid Antagonists from the Orvinol Series as Potential Reversal Agents for Opioid Overdose.
Disney A; Olson KM; Shafer AM; Moore SC; Anand JP; Traynor JR; Husbands SM
ACS Chem Neurosci; 2022 Nov; 13(21):3108-3117. PubMed ID: 36223082
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of law enforcement officer administered naloxone.
Gooley B; Weston B; Colella MR; Farkas A
Am J Emerg Med; 2022 Dec; 62():25-29. PubMed ID: 36215781
[TBL] [Abstract][Full Text] [Related]
12. Fact vs. fiction: naloxone in the treatment of opioid-induced respiratory depression in the current era of synthetic opioids.
Dahan A; Franko TS; Carroll JW; Craig DS; Crow C; Galinkin JL; Garrity JC; Peterson J; Rausch DB
Front Public Health; 2024; 12():1346109. PubMed ID: 38481848
[TBL] [Abstract][Full Text] [Related]
13. Noradrenergic Mechanisms in Fentanyl-Mediated Rapid Death Explain Failure of Naloxone in the Opioid Crisis.
Torralva R; Janowsky A
J Pharmacol Exp Ther; 2019 Nov; 371(2):453-475. PubMed ID: 31492824
[TBL] [Abstract][Full Text] [Related]
14. Modeling of overdose and naloxone distribution in the setting of fentanyl compared to heroin.
Coffin PO; Maya S; Kahn JG
Drug Alcohol Depend; 2022 Jul; 236():109478. PubMed ID: 35588609
[TBL] [Abstract][Full Text] [Related]
15. Association of Fentanyl Test Strip Use, Perceived Overdose Risk, and Naloxone Possession among People Who Use Drugs.
Tilhou AS; Zaborek J; Baltes A; Salisbury-Afshar E; Malicki J; Brown R
Subst Use Misuse; 2024; 59(2):254-257. PubMed ID: 37807227
[No Abstract] [Full Text] [Related]
16. On the front lines of the opioid epidemic: Rescue by naloxone.
Skolnick P
Eur J Pharmacol; 2018 Sep; 835():147-153. PubMed ID: 30092179
[TBL] [Abstract][Full Text] [Related]
17. Higher doses of naloxone are needed in the synthetic opiod era.
Moss RB; Carlo DJ
Subst Abuse Treat Prev Policy; 2019 Feb; 14(1):6. PubMed ID: 30777088
[TBL] [Abstract][Full Text] [Related]
18. Sentanyl: a comparison of blood fentanyl concentrations and naloxone dosing after non-fatal overdose.
Krotulski AJ; Chapman BP; Marks SJ; Ontiveros ST; Devin-Holcombe K; Fogarty MF; Trieu H; Logan BK; Merchant RC; Babu KM
Clin Toxicol (Phila); 2022 Feb; 60(2):197-204. PubMed ID: 34278904
[TBL] [Abstract][Full Text] [Related]
19. The need for multiple naloxone administrations for opioid overdose reversals: A review of the literature.
Abdelal R; Banerjee AR; Carlberg-Racich S; Darwaza N; Ito D; Epstein J
Subst Abus; 2022; 43(1):774-784. PubMed ID: 35112993
[No Abstract] [Full Text] [Related]
20. Development of a Translational Model to Assess the Impact of Opioid Overdose and Naloxone Dosing on Respiratory Depression and Cardiac Arrest.
Mann J; Samieegohar M; Chaturbedi A; Zirkle J; Han X; Ahmadi SF; Eshleman A; Janowsky A; Wolfrum K; Swanson T; Bloom S; Dahan A; Olofsen E; Florian J; Strauss DG; Li Z
Clin Pharmacol Ther; 2022 Nov; 112(5):1020-1032. PubMed ID: 35766413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
